Voluntary Recall of Marcaine 0.5% by Hospira: AttorneyOne Monitor and Keep Consumers Informed posted by on

On June 18, the FDA published a voluntary recall for one lot of Marcaine (Bupivacaine HCI Injection, USP), 0.5 percent, 30 ML, Single-Dose, Preservative-Free, by Hospira, due to visible particulates. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers.


San Diego, CA (PRWEB) June 19, 2014

AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on Marcaine.

The FDA announced on June 18, the voluntary recall for one lot of Marcaine (Bupivacaine HCI Injection, USP), 0.5 percent, 30 ML, Single-Dose, Preservative-Free, by Hospira, due to visible particulates. The affected lot number is 33-545-DD and was distributed from November 2013 through March 2014.

This recall is based on a confirmed customer report of particulate embedded in the glass vial as well as visible particulate in the solution attributed by the company to a suppliers glass defect.

Administration of the specific product can lead to a delay in therapy. Moreover, exposure to strong magnetic fields (e.g. MRI) could potentially dislodge the particulate causing tissue damage.

Taking into consideration the latest developments, AttorneyOne.com monitor daily and update the website providing accurate information on all relevant FDA safety alerts. Sean Burke, director of Media Relations at AttorneyOne.com, adds we are determined to keep an eye on FDA announcements concerning Marcaine and inform the public. For that reason”, he continues, “our focus should squarely fall on investigating these safety alerts and getting the word out.

The FDA advises consumers Anyone with an existing inventory should immediately stop use and quarantine any affected product. In addition, customers should inform potential users of this product in their organizations of this notification. And the Agency adds Hospira will be notifying its direct distributors/customers via a recall letter and will arrange for impacted product to be returned to Stericycle for returns processing.

AttorneyOne.com has further information on Marcaine at the website including latest major drug and medical products law news.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2014/06/prweb11953377.htm





Support This Blog By Visiting Marketing Campaign on the topic of 10bet :
10bet


9 Responses to “Voluntary Recall of Marcaine 0.5% by Hospira: AttorneyOne Monitor and Keep Consumers Informed”

Leave a Reply